9-122144359-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014222.3(NDUFA8):āc.401A>Gā(p.Asp134Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,614,158 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014222.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NDUFA8 | NM_014222.3 | c.401A>G | p.Asp134Gly | missense_variant | 4/4 | ENST00000373768.4 | NP_055037.1 | |
NDUFA8 | NM_001318195.2 | c.381+3753A>G | intron_variant | NP_001305124.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NDUFA8 | ENST00000373768.4 | c.401A>G | p.Asp134Gly | missense_variant | 4/4 | 1 | NM_014222.3 | ENSP00000362873 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152176Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000760 AC: 19AN: 250156Hom.: 0 AF XY: 0.0000739 AC XY: 10AN XY: 135316
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1461864Hom.: 0 Cov.: 32 AF XY: 0.0000206 AC XY: 15AN XY: 727246
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152294Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 10, 2021 | The c.401A>G (p.D134G) alteration is located in exon 4 (coding exon 4) of the NDUFA8 gene. This alteration results from a A to G substitution at nucleotide position 401, causing the aspartic acid (D) at amino acid position 134 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at